Scientists have found a potential new drug target for untreatable fatty liver disease in humans, according to a study published today in eLife.
Aug 15, 2023
0
3
In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH). Now a study has found that empagliflozin, a newer ...
Mar 19, 2018
0
64
Treating ovariectomized mice with a combination of conjugated estrogens and the drug bazedoxifene triggers the expression of genes that improve metabolism and prevent weight gain – without stimulating the uterus and increasing ...
Dec 22, 2017
0
9
In mice that are fed a high-fat diet, an increased production of the enzyme DPP4 by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance. These were the findings of a study ...
Aug 25, 2017
0
1
The role of dietary fructose in the development of obesity and fatty liver diseases remains controversial, with previous studies indicating that the problems resulted from fructose and a diet too high in calories.
Jun 19, 2013
3
0
The 150 minutes of moderate to intense aerobic activity per week that is recommended by the U.S. Department of Health and Human Services can significantly reduce liver fat, according to new research by Penn State College ...
Feb 8, 2023
0
12
Professor David Ray, from The University of Manchester, lead the research which found that out of 752 genes which regulate lungs in mice, 230 genes work only in the day and only 197 at night.
Sep 4, 2018
0
16
Research by Oregon State University suggests a pair of compounds originating from hops can help thwart a dangerous buildup of fat in the liver known as hepatic steatosis.
Jun 15, 2021
0
8
Women have long bemoaned the fact that as they have more children, their weight gain from pregnancy becomes more difficult to lose. A new study using a mouse model that mimics the human effects of multiparity (giving birth ...
Jan 26, 2012
0
0
Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring. NASH may progress to cirrhosis of the liver and liver cancer, ...
Nov 21, 2016
0
3
